Review of consensus interferon in the treatment of chronic hepatitis C.
about
New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agentsDesign and evaluation of novel interferon lambda analogs with enhanced antiviral activity and improved drug attributes.Hepatitis C viremia and genotype distribution among a sample of nonmedical prescription drug users exposed to HCV in rural Appalachia.IFN-α subtypes: distinct biological activities in anti-viral therapy.Consensus interferon plus ribavirin for hepatitis C genotype 3 patients previously treated with pegylated interferon plus ribavirin.Peginterferon Alfa-2a/Ribavirin treatment efficacy in chronic hepatitis C patients is related to natural killer group 2D gene rs1049174 GC polymorphism.
P2860
Review of consensus interferon in the treatment of chronic hepatitis C.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Review of consensus interferon in the treatment of chronic hepatitis C.
@en
Review of consensus interferon in the treatment of chronic hepatitis C.
@nl
type
label
Review of consensus interferon in the treatment of chronic hepatitis C.
@en
Review of consensus interferon in the treatment of chronic hepatitis C.
@nl
prefLabel
Review of consensus interferon in the treatment of chronic hepatitis C.
@en
Review of consensus interferon in the treatment of chronic hepatitis C.
@nl
P2860
P356
P1476
Review of consensus interferon in the treatment of chronic hepatitis C.
@en
P2093
Th Witthöft
P2860
P304
P356
10.2147/BTT.S1852
P577
2008-12-01T00:00:00Z